P-279: Efficacy, safety, and pharmacokinetics of iberdomide plus dexamethasone in patients with relapsed/refractory multiple myeloma by renal function: a subgroup analysis of the CC-220-MM-001 trial

Authors :: Niels W.C.J. van de Donk
Marc S. Raab
Britta Besemer
David S. Siegel
Faiz Anwer
Brea Lipe
Darrell White
Abdullah Khan
Matthew J. Pianko
Yiming Cheng
Lu Chen
Hongxia Lin
Paulo Maciag
Joshua Emerson
Alpesh Amin
Sagar Lonial
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S191-S192
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools